Theorem Clinical Research

AstraZeneca

Premier Research names Martin Nicklasson to board of directors

Friday, May 30, 2014 01:10 PM

CRO Premier Research has appointed Martin Nicklasson, Ph.D., to its board of directors.

More... »


Discovery Labs adds to scientific leadership team

Friday, May 23, 2014 12:23 PM

Discovery Laboratories, a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, has strengthened its scientific leadership. Effective immediately, Steve Simonson, M.D., M.H.S., has joined the company as vice president, Clinical Development, and Lawrence Weinstein has joined as vice president, Medical Device Development.

More... »


Human Longevity hires for clinical, regulatory/scientific and informatics

Thursday, May 22, 2014 10:43 AM

Human Longevity (HLI), a genomics and cell therapy-based diagnostic and therapeutic company, has announced three senior appointments to help build the company's business and technology platforms.

More... »

AstraZeneca rejects Pfizer’s “final” acquisition offer

Monday, May 19, 2014 12:02 PM

Barely nine hours after Pfizer made its fourth and “final” takeover offer, raising it to $118 billion, AstraZeneca rejected it today, ending the U.S. pharma giant’s plan to create the world’s largest biopharmaceutical company.

More... »

AstraZeneca, MRC Laboratory of Molecular Biology to launch joint research fund

Friday, May 16, 2014 12:47 PM

AstraZeneca will collaborate with the Medical Research Council Laboratory of Molecular Biology (MRC LMB) to fund a range of preclinical research projects aimed at better understanding the biology of disease.

More... »

Ligand, Omthera ink agreement for dyslipidemia

Thursday, May 15, 2014 01:21 PM

Ligand Pharmaceuticals has entered into a licensing agreement and research collaboration with Omthera Pharmaceuticals, a wholly-owned subsidiary of AstraZeneca, for the development of products to treat dyslipidemia, including hypertriglyceridemia.

More... »

Incyte, MedImmune collaborate on immuno-oncology clinical trial

Wednesday, May 14, 2014 01:30 PM

Incyte, a Wilmington, Del.-based biopharmaceutical company, and MedImmune, the global biologics R&D arm of AstraZeneca, have entered into a clinical study collaboration. The phase I/II oncology study will evaluate the efficacy and safety of MedImmune’s investigational anti-PD-L1 immune checkpoint inhibitor, MEDI4736, in combination with Incyte’s oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360.

More... »

FDA approves EPANOVA for severe hypertriglyceridemia

Wednesday, May 7, 2014 02:43 PM

AstraZeneca has announced the FDA approved EPANOVA (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500mg/dL).

More... »

Pfizer pursues AstraZeneca for potential $100 billion acquisition deal

Monday, April 28, 2014 02:15 PM

Having rejected two bids since January, Pfizer made its next move on Monday—a $99 billion stock and cash offer to acquire AstraZeneca, to create a single U.K.-based company that would become the world’s largest pharmaceutical company.

More... »

GSK, Novartis, Eli Lilly swap assets to specialize, become more profitable

Wednesday, April 23, 2014 08:42 AM

In a major swap of assets, three of the world’s largest drug companies have announced a multi-part, $28.5 billion deal that enables Novartis to focus more on cancer, GlaxoSmithKline on vaccines and Eli Lilly on animal health.

More... »

CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private ἀnancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs